INTERBRI · CHINA MARKET ACCESS FOR MEDICAL DEVICES China-focused support. Clear scope. Accountable coordination.
Practice Q&A

Post-market Obligations & Vigilance Q&A

8 min readPost-market focus

Receiving the registration or filing is not the finish line — it is the start of continuing obligations. Post-market surveillance, reporting and recalls are precisely the area where overseas manufacturers have the least feel: they generate no revenue, yet they directly affect renewal and your right to stay on the market. Below are the questions we hear most, answered from practice.

QWhat continuing obligations does the holder have after market approval?

Core duties run through the whole lifecycle: maintaining the quality management system, conducting adverse event monitoring and re-evaluation, establishing product traceability, taking risk-control measures such as recalls when required, and managing renewal and changes of the registration. Continued conformity of technical requirements, labelling and IFU control, and compliant promotional claims also belong to the post-market scope.

QDo foreign holders also need vigilance in China? Who does the work?

Yes. Overseas registrants and record-holders carry the same monitoring obligations as domestic holders. In practice the China legal agent assists: setting up monitoring procedures, collecting reports from the Chinese market, reporting to the vigilance system within statutory timelines, and linking with the holder's global quality system. Define boundaries, deadlines and information flows clearly in the mandate agreement.

QAre there reporting timelines for adverse events?

Yes. Under the current vigilance and re-evaluation rules, events involving death must be reported within 7 days of awareness; serious injury, or events that could lead to death or serious injury, within 20 days; other reportable events have their own timelines. The clock starts on the date of awareness — so clear internal escalation and agent hand-offs are the precondition for meeting deadlines. Always check the current regulations.

QWhen is a recall triggered, and who initiates it?

When a marketed device is defective — carrying unreasonable risks to health and safety — the holder shall recall proactively, report to the authorities per recall levels, and notify distributors and users. Where an investigation shows a recall is needed and the holder fails to act, the authority can order one. Complaints and adverse events are the main entry points; response speed reflects system maturity.

QWhat does the China legal agent do post-market?

Typically: reporting adverse events to the authorities on the holder's behalf, cooperating in recalls and other regulatory measures, handling post-market-related registration affairs, and keeping the holder informed of regulatory changes in China. The agent is your on-the-ground anchor — when selecting one, assess vigilance responsiveness and recall execution, not only registration delivery.

QHow do these records tie into renewal?

Heavily. Renewal requires a summary of QMS operation and adverse event monitoring across the registration cycle. Incomplete monitoring records or unresolved risk signals can directly affect the renewal review. Keeping monitoring logs, complaint handling and recall drills well documented is what makes renewal a formality rather than a scramble — hence our advice to archive by registration cycle.

QCan labels and IFUs still be changed after market entry?

They are controlled content fixed by the registration: any post-market modification must first be assessed for whether it triggers a change submission — no free edits. Updates to UDI, lifetime or storage conditions carry their own requirements. Run a change-classification check first, then decide between substantive change, record change or internal controlled update.

QHow do we build a post-market system that is good enough?

Overseas manufacturers rarely need to build a large system from scratch, but four loops must close: vigilance (collect — assess — report), change (identify — classify — execute), records (archive by cycle) and communication (holder — agent — distributor information flows). Run an annual internal review that cross-checks the agent's execution reports; most issues surface in self-inspection.

These answers are general summaries and do not constitute legal advice; specific obligations, timelines and procedures follow China's current regulations and the authorities' rules. For a product-specific post-market arrangement, talk to us.
Back to the Regulation Library